The company specializes in contract manufacturing and is currently manufacturing for many reputed pharma companies, with growing product offering and clientele. Cris has been a reliable and trusted partner of the healthcare industries with a history of proven regulatory compliance. We currently manufacture products on contract basis at our facility for various leading pharmaceutical companies both for the Domestic as well as Export markets. The quality service delivered by Cris is one major reason that pharmaceutical companies opt to entrust manufacturing of their products with us. Our systems promote consistent quality in production while maintaining cost efficiencies. Our expertise in contract manufacturing has won us appreciation across the country and has helped us maintain a clientele that is satisfied with our value based quality services.
Manufacturing
- Home
- Manufacturing
Contract Manufacturing
-
Exports
-
Besides providing contract manufacturing services to many leading Indian MNCs to meet their domestic and export market requirements, Cris has pierced into international Pharmaceutical Market. Its manufacturing unit is also registered in Francophone countries. Cris has full-fledged team of professionals for International business and regulatory affairs, to prepare and submit dossiers as per CTD, ACTD and follow the guidelines of MOH of different countries. Cris is now poised to become a leading exporter of Drugs and Medicines from India and is all set to commencebusiness in abroad. Cris has recently started its export operations in Nigeria, Myanmar, Ghana, Kenya, & Uganda.
-
Why Choose Cris Pharma?
-
The facility is WHO-GMP Certified. We currently Contract Manufacture products at our facility for various leading pharmaceutical Companies both for the Domestic & Export markets.
-
CRIS`s standard of quality is one reason that major pharmaceutical companies chose to entrust manufacturing of their products with us. We serve our customers with experienced staff and state of the art equipment. Our Systems promote consistent quality in production while maintaining cost efficiencies.
-
Formulation research and development, stability studies, validation studies, new method development
Periodic and accelerated stability studies and validation studies and new method development are conducted in-house. This is a continuous in-house activity at Cris. Latest formulations and new techniques including direct compression, aqueous coating, enteric coating, etc. are used to manufacture modified release/sustained release formulations, dispersible, bi-layer tablets etc.